| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.36% |
| NAV | ₹10.24 (29 Sep 2020) |
|---|---|
| Fund Started | 28 Sep 2017 |
| Fund Size | ₹357 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Infosys Ltd. | Technology | Equity | 8.8% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 7.2% |
| ICICI Bank Ltd. | Financial | Equity | 6.6% |
| Multi Commodity Exchange India | Financial | Equity | 6.4% |
| Gujarat Gas Ltd. | Chemicals | Equity | 5.7% |
| Axis Bank Ltd. | Financial | Equity | 5.2% |
| Cipla Ltd. | Healthcare | Equity | 4.9% |
| Eicher Motors Ltd. | Automobile | Equity | 4.7% |
| PI Industries Ltd. | Chemicals | Equity | 4.4% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 4.3% |
UTI Focussed Equity Fund Series IV (1104 Days) Regular Growth is a Equity Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 28 Sep 2017. Vetri Subramaniam, Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series IV (1104 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹357 Cr and the Latest NAV as of 29 Sep 2020 is ₹10.24.
The UTI Focussed Equity Fund Series IV (1104 Days) Regular Growth is rated Moderately High risk.